Analyst Recommendations

Goldman Sachs analyst issues NEUTRAL recommendation for BAYRY on May 30, 2024 04:30AM ET. BAYRY was trading at $7.31 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   BAYRY -1.24%

Goldman Sachs analyst issues BUY recommendation for BSX on May 30, 2024 04:29AM ET. BSX was trading at $74.98 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   BSX 0.08%

Goldman Sachs analyst issues BUY recommendation for EW on May 30, 2024 04:30AM ET. EW was trading at $87.03 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   EW 0.13%

Goldman Sachs analyst issues BUY recommendation for NVS on May 30, 2024 04:29AM ET. NVS was trading at $99.36 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   NVS 0.42%

Goldman Sachs analyst issues BUY recommendation for NVO on May 30, 2024 04:28AM ET. NVO was trading at $132.68 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   NVO 3.72%

Goldman Sachs analyst issues BUY recommendation for ISRG on May 30, 2024 04:32AM ET. ISRG was trading at $398.4 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   ISRG -0.76%

Goldman Sachs analyst issues BUY recommendation for AZN on May 30, 2024 04:35AM ET. AZN was trading at $76.08 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   AZN 0.54%

Goldman Sachs analyst issues BUY recommendation for ABT on May 30, 2024 04:34AM ET. ABT was trading at $100.73 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   ABT 0.60%

Goldman Sachs analyst issues NEUTRAL recommendation for GSK on May 30, 2024 04:34AM ET. GSK was trading at $44.28 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   GSK 1.54%

Exane BNP Paribas analyst issues OUTPERFORM recommendation for SPSAF on May 30, 2024 04:36AM ET. SPSAF was trading at $238.27 at issue of the analyst recommendation.The overall analyst...

May 30, 2024   SPSAF -0.01%